Medacist
Healthcare Software · Connecticut, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1492 Highland Ave Ste 4, Cheshire, Conne...Phone Number
(866) 633-5393Website
www.medacist.comRevenue
$13.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
2
1
1
1
About Medacist
Headquartered in Cheshire, CT, Medacist is a leading innovator in drug diversion analytics. With the only U.S. patent in this discipline, the company applies artificial intelligence (AI), machine learning and data analytics to clients' data in order to pinpoint unusual patterns throughout the lifecycle of drugs-from procurement, to storage and management in a clinical pharmacy, to prescription and dispensation by doctors and nurses, to administration to the patient. Using Medacist's suite of analytic services, built on Genesis healthcare data platform, healthcare providers can identify possible abuse patterns for further investigation and action.Explore more
Medacist Org Chart
AM
Senior DevOps Engineer
VS
Lead Data Engineer
MK
Data Engineer
AD
Sales & Marketing Support Analyst
MC
Quality Assurance Analyst
MD
Account Specialist
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Medacist your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Medacist is spiking on competitors!
Earning: See what the market has to say on Medacist recently announced quarterly report
Product Launch: Get notified when Medacist launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Medacist, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Medacist has new funding data
Check if Medacist has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Medacist
Click to see if Medacist had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Medacist
Compare insights from companies similar to Medacist, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$16.1M
51-200
Private
$7.5M
2012
HH
Hector HernandezSenior Manager, At Eagledream Technologies, Part of The Pwc Network
Company Profile Activity
Activity Insights
Medacist is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Medacist is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Medacist.
Medacist financials insights
Gather financial insights about Medacist, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Medacist Tech Stack
A closer look at the technologies used by Medacist
See more technologies
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions (M&A)
Funding
Medacist has received an SBA PPP loan for $150,000-350,000 from Webster Bank, supporting the retention of 18 jobs.
Funding
Medacist News & Media
Thoma Bravo supports Bluesight's Medacist acquisition
Thoma Bravo supports Bluesight's Medacist acquisition Submitted 18/07/2023 - 11:26am Software-focused private investment major Thoma Bravo has closed a strategic growth investment in Bluesight, a provider of pharmacy software solutions, to support the company's acquisition of Medacist, a specialist in drug diversion monitoring. Financial terms of the transaction, which will see current Bluesight investor New Leaf Ventures remain invested in the business, have not been disclosed. Bluesight's visiThoma Bravo invests in medication intelligence firm Bluesight
The investment will be used to back Bluesight's acquisition of Medacist, a drug diversion monitoring firm. The post Thoma Bravo invests in medication intelligence firm Bluesight appeared first on PE Hub.Medacist Expands Relationship with a Houston Hospital System
CHESHIRE, Conn., Jan. 13, 2022 /PRNewswire/ -- Medacist, the industry leader in drug diversion technology solutions, today announced the expansion of their relationship to provide RxAuditor Investigate™ to Houston Methodist, a leading hospital system comprised of an academic medical...Medacist Unveils RxDiversion Scorecard
CHESHIRE, Conn., April 5, 2021 /PRNewswire/ -- Medacist, the industry leader in drug diversion technology solutions, today launched the Medacist RxDiversion Scorecard, a new online set of guidelines to help hospitals and healthcare institutions understand their specific needs and evaluate...
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Medacist
Sign Up For FreeTo access detailed company insights
Headquartered in Cheshire, CT, Medacist is a leading innovator in drug diversion analytics. With the only U.S. patent in this discipline, the company applies artificial intelligence (AI), machine learning and data analytics to clients' data in order to pinpoint unusual patterns throughout the lifecycle of drugs-from procurement, to storage and mana... Read More
